Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05972837

Effects of Home-based Surface Electrical Stimulation for Patients with Cervical Myofascial Pain Syndrome

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Taipei Medical University WanFang Hospital · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare the developed home-based surface electrical stimulation program to the controls in computer office workers with MPS.

Detailed description

Cervical myofascial pain syndrome (MPS) is a common problem among workers who have large amount of computer use. Additionally, owing to the high workload and long hours of staying in thier cubicle, the office employees are often unable to have extra time to receive rehabilitation and treatment regularly. A home-based surface electrical stimulation (SES) program is developed to help intervention be time-saving and more accessible for office-based staff busy at work. In this single-blind randomized controlled trial, participants will be assigned to one of the following three groups and undergo 3 weeks (20 minutes/ time, three times/ week) of intervention: 1. SES combined with telemedical support 2. SES 3. No intervention The outcome assessments will be performed before and after the intervention (0-wk and 4-wk) and 4 weeks after the endpoint of intervention (8-wk). The outcome assessor was blind to the intervention and group allocation.

Conditions

Interventions

TypeNameDescription
DEVICESurface electrical stimulation (SES)Participants will undergo 3 weeks (20 minutes/ time, three times/ week) of SES intervention.
OTHERRemote medical supportThe remote medical support includes a session of video call with a rehabilitation doctor in the first week and weekly telehealth visits with a live physical therapist or physician. The contents of the video calls contain patient education, stretching exercises teaching and instructions of using SES for MPS.

Timeline

Start date
2023-08-04
Primary completion
2025-08-01
Completion
2025-11-01
First posted
2023-08-02
Last updated
2025-01-17

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05972837. Inclusion in this directory is not an endorsement.